Edition:
United States

AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,612.50GBp
22 Jul 2016
Change (% chg)

89.00p (+1.97%)
Prev Close
4,523.50p
Open
4,546.50p
Day's High
4,616.50p
Day's Low
4,529.00p
Volume
2,403,598
Avg. Vol
2,690,720
52-wk High
4,634.00p
52-wk Low
3,680.00p

Reports per page
Select Report Title Date Provider Pgs Price
Trading Report for (AZN). A detailed report, including free correlated market analysis, and updates. 22 Jul 2016 Stock Traders Daily 6 20.00
AstraZeneca PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 22 Jul 2016 Reuters Investment Profile 12 20.00
Thomson Reuters Stock Report - AstraZeneca PLC (AZN-LN) 22 Jul 2016 Thomson Reuters Stock Report 11 25.00
AZN: Due Diligence Review: Forensic Earnings and Valuation 21 Jul 2016 New Constructs, LLC 10 25.00
Value Graph: ASTRAZENECA PLC -- AZN 21 Jul 2016 Ford Investor Services, Inc. 1 12.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ASTRAZENECA PLC -ADR including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 21 Jul 2016 Jefferson Research 11 20.00
"The Economy Matters" Report for AZNCF: the economy's impact on AZNCF's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 19 Jul 2016 MacroRisk Analytics/EconomicInvestor 8 25.00
"The Economy Matters" Report for AZN.H: the economy's impact on AZN.H's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 18 Jul 2016 MacroRisk Analytics/EconomicInvestor 8 25.00
AstraZeneca PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 16 Jul 2016 Reuters Investment Profile 12 20.00
AZN.L - Event Transcript of AstraZeneca PLC conference call, Apr. 29, 2016 / 7:00AM ET 29 Apr 2016 Thomson Reuters StreetEvents 24 75.00
 
Name Age Since Current Position

Leif Johansson

65 2012 Independent Non-Executive Chairman of the Board

Pascal Soriot

56 2012 Chief Executive Officer, Executive Director

Marc Dunoyer

62 2013 Chief Financial Officer, Executive Director

Fiona Cicconi

2014 Executive Vice-President, Human Resources

Sean Bohen

2015 Chief Medical Officer, Executive Vice President - Global Medicines Development